The cost of outpatient (OP) ripening in the US is unknown. We aim to evaluate potential cost of OP versus inpatient (IP) ripening with transcervical balloon catheters in term patients with unfavorable cervix, and determine the circumstances in which OP ripening could be cost-neutral or even cost-saving. STUDY DESIGN: We created a decision model to compare OP and IP ripening with transcervical balloon catheters in a population of term (>37 weeks) patients with singleton pregnancies, unfavorable cervix, and no contraindications to labor. We performed a cost-minimization analysis and threshold analyses comparing the two interventions. Existing data support the safety and efficacy of OP ripening, so effectiveness was assumed to be equal for successful vaginal delivery and perinatal outcomes. Base case estimates of probability, utilization, and cost were derived from the literature. Costs included those generated by OP visit, fetal monitoring preand post-catheter placement, potential triage visits, and hours on labor and delivery (L&D). In reviewing the literature, we assumed that the average time saved on L&D was 6.5 hours, 20-50% of patients in the cohort were ineligible or unwilling to complete OP ripening, and 9% required a triage visit after OP placement. The primary outcome was incremental cost of OP versus IP ripening from a hospital perspective. Sensitivity analyses examined broad versus limited use of OP ripening. One-and two-way sensitivity analyses evaluated validity of the model under multiple scenarios. RESULTS: In the base-case analysis, OP ripening was cost-saving compared to IP ripening: $156.83 saved per patient; more limited use of OP ripening yielded lower savings (Table) . OP ripening was cost-saving if average time saved on L&D from OP ripening was >3.5 hours, insertion visit cost was <$650.07, or facility cost per L&D hour was >$63.95. In contrast, the model was not sensitive to the proportion of patients eligible or completing OP ripening, or to the cost or proportion of triage visits. OP ripening was cost saving under the majority of plausible clinical circumstances ( Figure) . CONCLUSION: In patients with unfavorable cervix, the use of outpatient (OP) transcervical balloon catheter for ripening is cost-saving under a wide range of plausible clinical circumstances, specifically if the time saved on L&D is >3.5 hours. Taken together with safety and feasibility data, these data support the practice of OP ripening in appropriately-selected patients.
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